These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 17127294)

  • 1. Osteopontin: a novel inflammatory mediator of cardiovascular disease.
    Singh M; Ananthula S; Milhorn DM; Krishnaswamy G; Singh K
    Front Biosci; 2007 Jan; 12():214-21. PubMed ID: 17127294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Osteopontin in cardiovascular disease: a potential therapeutic target.
    Waller AH; Sanchez-Ross M; Kaluski E; Klapholz M
    Cardiol Rev; 2010; 18(3):125-31. PubMed ID: 20395697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Osteopontin in Vascular Disease.
    Lok ZSY; Lyle AN
    Arterioscler Thromb Vasc Biol; 2019 Apr; 39(4):613-622. PubMed ID: 30727754
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease.
    Scatena M; Liaw L; Giachelli CM
    Arterioscler Thromb Vasc Biol; 2007 Nov; 27(11):2302-9. PubMed ID: 17717292
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Osteopontin mediates macrophage chemotaxis via α4 and α9 integrins and survival via the α4 integrin.
    Lund SA; Wilson CL; Raines EW; Tang J; Giachelli CM; Scatena M
    J Cell Biochem; 2013 May; 114(5):1194-202. PubMed ID: 23192608
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Osteopontin: a key cytokine in cell-mediated and granulomatous inflammation.
    O'Regan A; Berman JS
    Int J Exp Pathol; 2000 Dec; 81(6):373-90. PubMed ID: 11298186
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Peptide-based vaccination against OPN integrin binding sites does not improve cardio-metabolic disease in mice.
    Grün NG; Strohmeier K; Moreno-Viedma V; Le Bras M; Landlinger C; Zeyda K; Wanko B; Leitner L; Staffler G; Zeyda M; Stulnig TM
    Immunol Lett; 2016 Nov; 179():85-94. PubMed ID: 27639826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Expression, roles, receptors, and regulation of osteopontin in the kidney.
    Xie Y; Sakatsume M; Nishi S; Narita I; Arakawa M; Gejyo F
    Kidney Int; 2001 Nov; 60(5):1645-57. PubMed ID: 11703581
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The multiple functions and mechanisms of osteopontin.
    Icer MA; Gezmen-Karadag M
    Clin Biochem; 2018 Sep; 59():17-24. PubMed ID: 30003880
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Osteopontin promotes integrin activation through outside-in and inside-out mechanisms: OPN-CD44V interaction enhances survival in gastrointestinal cancer cells.
    Lee JL; Wang MJ; Sudhir PR; Chen GD; Chi CW; Chen JY
    Cancer Res; 2007 Mar; 67(5):2089-97. PubMed ID: 17332338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pathophysiological role of osteopontin in hepatic inflammation, toxicity, and cancer.
    Ramaiah SK; Rittling S
    Toxicol Sci; 2008 May; 103(1):4-13. PubMed ID: 17890765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteopontin - a multi-modal marker and mediator in atherosclerotic vascular disease.
    Wolak T
    Atherosclerosis; 2014 Oct; 236(2):327-37. PubMed ID: 25128758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteopontin as a new player in mast cell biology.
    Bulfone-Paus S; Paus R
    Eur J Immunol; 2008 Feb; 38(2):338-41. PubMed ID: 18228246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of osteopontin in regulating hepatic inflammatory responses and toxic liver injury.
    Ramaiah SK; Rittling S
    Expert Opin Drug Metab Toxicol; 2007 Aug; 3(4):519-26. PubMed ID: 17696803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopontin alters endothelial and valvular interstitial cell behaviour in calcific aortic valve stenosis through HMGB1 regulation.
    Passmore M; Nataatmadja M; Fung YL; Pearse B; Gabriel S; Tesar P; Fraser JF
    Eur J Cardiothorac Surg; 2015 Sep; 48(3):e20-9. PubMed ID: 26273067
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteopontin, intrinsic tissue regulator of intractable inflammatory diseases.
    Uede T
    Pathol Int; 2011 May; 61(5):265-80. PubMed ID: 21501293
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of osteopontin in cardiovascular diseases].
    Witkiewicz W; Czyzewska-Buczyńska A; Bałasz S; Gnus JJ
    Pol Merkur Lekarski; 2010 Aug; 29(170):79-83. PubMed ID: 20842817
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Coordinate expression of OPN and associated receptors during monocyte/macrophage differentiation of HL-60 cells.
    Atkins K; Berry JE; Zhang WZ; Harris JF; Chambers AF; Simpson RU; Somerman MJ
    J Cell Physiol; 1998 May; 175(2):229-37. PubMed ID: 9525482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Osteopontin modulates CD44-dependent chemotaxis of peritoneal macrophages through G-protein-coupled receptors: evidence of a role for an intracellular form of osteopontin.
    Zhu B; Suzuki K; Goldberg HA; Rittling SR; Denhardt DT; McCulloch CA; Sodek J
    J Cell Physiol; 2004 Jan; 198(1):155-67. PubMed ID: 14584055
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immobilized Osteopontin Enhances Adhesion but Suppresses Cytokine Release of Anti-IgE Activated Human Mast Cells.
    Ng CW; Tam IYS; Sam SW; Yu Y; Lau HYA
    Front Immunol; 2018; 9():1109. PubMed ID: 29872439
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.